Apollo Cancer Centres launches ‘End-O Check’ – an early screening & diagnosis program for endometrial & ovarian cancers

New Delhi: Apollo Cancer Centres (ACCs) has launched End-O Check, a comprehensive early detection program targeting women aged 45 and above. The initiative is designed to detect two of the most prevalent gynaecologic cancers—endometrial and ovarian—at an early and more treatable stage.

End-O Check is designed with a focus on early detection in high-risk populations, symptom awareness, and timely intervention, empowering women to take proactive steps for their gynaecologic health.

Speaking at the launch, Dinesh Madhavan, President, Group Oncology & International, Apollo Hospitals Enterprise Ltd, said, “Early detection remains our most powerful ally in improving survival and quality of life in cancer care. End O Check is a proactive step in shifting the narrative from treatment to screening and early diagnosis , enabling timely detection, and precision treatment by cancer management teams “.

Shivakumar Pattabhiraman, Managing Director, Indraprastha Apollo Hospitals, said, “With End-O Check, we are further extending our commitment to preventive oncology. This program goes beyond clinical protocols, it is about creating awareness, encouraging women to prioritize their health, and ensuring access to comprehensive screening solutions. Early detection not only saves lives but also allows us to provide more effective, less invasive treatments.”

Ovarian cancer, often referred to as the “silent killer,” affects women between 55 and 64 years of age, with the average diagnosis occurring at 63. When caught early, the five-year survival rate exceeds 90%.

In India, the total cancer cases are projected to grow to 1.57 million by 2025, with ovarian and uterine cancers continuing to report among the top five cancers affecting women. The age-standardized incidence rates are estimated at 4.6 per 100,000 for ovarian cancers and 2.5 per 100,000 for corpus uterine cancers^2. Contributing factors include shifts in reproductive patterns, urban lifestyles, and a rise in metabolic conditions, highlighting the urgent need for targeted  detection in high-risk populations.

While endometrial cancer often presents with symptoms such as unexpected bleeding or abnormal discharge, many women fail to report these signs early, leading to delayed diagnosis and poorer outcomes.

Dr Pakhee Agarwal, Senior Consultant – Gynaecology Oncology & Robotic Surgery, Apollo Cancer Centre, New Delhi, said, “Endometrial cancer has been on the rise in women above the age of 45 years, so early detection is crucial for better outcomes. Global data indicates a five years survival rate of around 96% for localized disease. However, survival rates drop substantially when diagnosis is delayed, underscoring the importance of timely detection. Key risk factors include obesity, diabetes, early menstruation, late menopause, and polycystic ovary syndrome (PCOS), all of which are becoming more prevalent among Indian women.”

Dr. Reeti, Senior Consultant, Radiology Department, Apollo Cancer Centre, New Delhi, said, “Radiology plays a crucial role in the early detection of gynaecologic cancers. Through End-O Check, we are integrating transvaginal ultrasonography (TVS) as the diagnostic tool to help identify subtle changes that could indicate early-stage ovarian or endometrial cancers. Early imaging intervention allows clinicians to act promptly, improving treatment options and outcomes for patients.”